Clinical Trials Directory

Trials / Completed

CompletedNCT04357834

WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories

Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories. The WAVE Study.

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

The aim is to develop a wearable-based ICU (intensive care unit) prediction algorithm for inpatients contracted with SARS-CoV-2. Inpatients with suspicion of COVID-19 or with confirmed SARS-CoV-2 infection will be included. The participants will be equipped with a smartwatch, which gathers physiological data throughout hospitalisation.

Detailed description

The SARS-CoV-2 pandemic puts an unprecedented burden on the healthcare system, specifically its healthcare providers and the resource demands for intensive care units (ICUs). To support effective care despite large case numbers, hospital operations urgently need improved decision support in early identification of patients at risk of an acute COVID-19 deterioration that requires ICU. The investigators aim at developing a wearable-based ICU algorithm for inpatients contracted with SARS-CoV-2. Inpatients on the general ward with suspicion of COVID-19 or with confirmed SARS-CoV-2 infection will be included. The participant will be equipped with a smartwatch and wear the device throughout the hospital stay until the patient (1) is discharged home, (2) is transferred to the ICU, or (3) palliative care is initiated. The smartwatch collects several physiological parameters (e.g. heart rate, heart rate variability, respiration rate, oxygen saturation). The collected data will be used to develop an ICU prediction algorithm to detect patients at risk of an acute COVID-19 deterioration that requires ICU.

Conditions

Interventions

TypeNameDescription
OTHEREquipment with smartwatch throughout hospital stay on the general wardParticipants with confirmed SARS-CoV-2 infection or suspicion of COVID-19 will be equipped with a smartwatch and wear the device throughout the hospital stay on the general ward.

Timeline

Start date
2020-10-22
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2020-04-22
Last updated
2021-08-26

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04357834. Inclusion in this directory is not an endorsement.